Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

Clinical trial NCT00117949 · COMPLETED

Trial details

NCT number: NCT00117949
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2002-04-01
Primary completion: 2004-01-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.